Pfizer Limited (BOM:500680)
4,822.80
+23.75 (0.49%)
At close: Jul 31, 2026
Pfizer Revenue
Pfizer had revenue of 6.53B INR in the quarter ending June 30, 2026, with 8.31% growth. This brings the company's revenue in the last twelve months to 25.70B, up 10.69% year-over-year. In the fiscal year ending March 31, 2026, Pfizer had annual revenue of 25.20B with 10.45% growth.
Revenue (ttm)
25.70B
Revenue Growth
+10.69%
P/S Ratio
8.59
Revenue / Employee
20.66M
Employees
1,244
Market Cap
220.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 25.20B | 2.38B | 10.45% |
| Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
| Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
| Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
| Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 56.32B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
| Viyash Scientific | 34.20B |
| AstraZeneca Pharma India | 22.76B |
| Caplin Point Laboratories | 21.87B |
Pfizer News
- 5 days ago - Pfizer Quarterly report: Q1 2027 - Filings
- 26 days ago - Pfizer announces Rs 75 per share final dividend with record date set for July 17, 2026 - Business Upturn
- 2 months ago - Pfizer Quarterly report: Q4 2026 - Filings
- 2 months ago - Pfizer Annual report: Q4 2026 - Filings
- 6 months ago - Pfizer Quarterly report: Q3 2026 - Filings
- 6 months ago - Pfizer appoints Nilesh Pendse as vaccines category lead; Manikantan Seshadrinathan exits senior management - Business Upturn
- 8 months ago - Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands - Business Upturn
- 9 months ago - Pfizer shares jump over 5% as Q2 profit rises 19% YoY on strong operational performance - Business Upturn